Why is supportive care important in myeloma?
Treating pediatric ALL with chimeric antigen receptor (CAR) T-cell therapy
Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL
Current research into JAK inhibitors - specifially ruxolitinib, pacritinib, and momelotinib
Haifa Kathrin Al-Ali
Examining changes over time in CLL cell surface markers to identify cells at different stages